InterOss Large Particle Anorganic Cancellous Bone Graft in 0.5cc Syringe (IOLGS050) SigmaGraft

A natural, anorganic cancellous bone grafting xenograft delivered in a pre-packed, sterile syringe., containing small granules calibrated between 0.25mm - 1.0mm. This mineral matrix serves as an osteoconductive scaffold for predictable bone regeneration.

Uses

• Micro Extraction Socket Preservation: Fills narrow single-rooted tooth sockets (such as lower incisors or small bicuspids) immediately following an extraction to stop alveolar ridge collapse
• Targeted Peri-Implant Defect Repair: Packs localized, tight bone gaps, fenestrations, or exposed thread lines surrounding newly seated dental implants
• Infrabony Periodontal Defects: Infiltrates precise, deep pockets and vertical defects around compromised tooth roots to help reconstruct the supportive attachment apparatus
• Localized Endodontic Void Filling: Rebuilds small, specific bony access windows following apicoectomies, root-end resections, or minor dental cystectomies

Features

• Ergonomic Delivery Syringe: Pre-loaded with sterile granules, allowing clinicians to extrude material directly into the target cavity without using secondary carrier instruments
• Fine Granule Calibration: Calibrated to a particle diameter of 0.25mm - 1.0mm (250–1000μm) to ensure favorable fill for smaller defects.
• Biomimetic Architecture: Structure mirrors human cancellous bone through interconnected macropores (100–600μm), mesopores (10–100μm), and micropores (<10μm)
• Chemistry: BSE-free Australian bovine bone via a thermal annealing process to remove organic cellular components, leaving a nanocrystalline calcium phosphate matrix

Benefits

• Instruments-Free Clinical Precision: Syringe design allows for placement at the base of narrow defects, reducing chair time, mitigating particle migration, and eliminating material waste.
• Hydrophillic: Quickly hydrates with patient blood or sterile saline instantly through the tip of the syringe.
• Architecture: Macropores promote rapid, early angiogenesis, while the open micropores supply high-surface-area for osteoblast binding and new bone deposition.
• Biocompatible: Resorbs slowly over 6 to 9 months, maintaining space and resisting soft tissue growth into the defect.

Tags: Xenograft